Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies

Publication Date

2022

Content Type

Article

PubMed ID:

35402914

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS